{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:23:47Z","timestamp":1788279827973,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-023-00601-5","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T09:01:43Z","timestamp":1695891703000},"page":"401-410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy and Safety of Azelnidipine as an Antihypertensive Compared to Amlodipine: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2738-082X","authenticated-orcid":false,"given":"Debkumar","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5249-1505","authenticated-orcid":false,"given":"Shampa","family":"Maji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4063-9178","authenticated-orcid":false,"given":"Rituparna","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"601_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","volume":"75","author":"FD Fuchs","year":"2020","unstructured":"Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75:285\u201392.","journal-title":"Hypertension"},{"key":"601_CR2","unstructured":"Hypertension [Internet]. World Heart Federation. https:\/\/world-heart-federation.org\/what-we-do\/hypertension\/ [cited 2023 Jan 7]."},{"key":"601_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/1074248414555403","volume":"20","author":"G Tocci","year":"2015","unstructured":"Tocci G, Battistoni A, Passerini J, Musumeci MB, Francia P, Ferrucci A, Volpe M. Calcium channel blockers and hypertension. J Cardiovasc Pharmacol Ther. 2015;20:121\u201330.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"601_CR4","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1097\/HJH.0000000000002145","volume":"37","author":"D Vukadinovi\u0107","year":"2019","unstructured":"Vukadinovi\u0107 D, Scholz SS, Messerli FH, Weber MA, Williams B, B\u00f6hm M, Mahfoud F. Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled trials. J Hypertens. 2019;37:2093\u2013103.","journal-title":"J Hypertens"},{"key":"601_CR5","first-page":"309","volume":"11","author":"BL Chen","year":"2015","unstructured":"Chen BL, Zhang YZ, Luo JQ, Zhang W. Clinical use of azelnidipine in the treatment of hypertension in Chinese patients. Ther Clin Risk Manag. 2015;11:309\u201318.","journal-title":"Ther Clin Risk Manag"},{"key":"601_CR6","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.2165\/00003495-200363230-00004","volume":"63","author":"K Wellington","year":"2003","unstructured":"Wellington K, Scott LJ. Azelnidipine. Drugs. 2003;63:2613\u201321.","journal-title":"Drugs"},{"key":"601_CR7","unstructured":"CDSCO. Recommendations of the SEC [Internet]; 2020. https:\/\/www.cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadCommitteeFiles\/73rdSECCardiovascular%20&%20Renal6fe20.pdf [cited 2022 Dec 24]."},{"key":"601_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1291\/hypres.28.1017","volume":"28","author":"T Shokoji","year":"2005","unstructured":"Shokoji T, Fujisawa Y, Kiyomoto H, Rahman M, Sun GP, Fan YY, Kimura S, Kohno M, Abe Y, Nishiyama A. Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats. Hypertens Res. 2005;28:1017\u201323.","journal-title":"Hypertens Res"},{"key":"601_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1291\/hypres.30.359","volume":"30","author":"M Nakamoto","year":"2007","unstructured":"Nakamoto M, Ohya Y, Sakima A, Yamazato M, Takishita S. Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats. Hypertens Res. 2007;30:359\u201366.","journal-title":"Hypertens Res"},{"key":"601_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MAJ.0b013e318065c254","volume":"333","author":"T Nakamura","year":"2007","unstructured":"Nakamura T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H, Inoue T, Node K. Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease. Am J Med Sci. 2007;333:321\u20136.","journal-title":"Am J Med Sci"},{"key":"601_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1159\/000338132","volume":"35","author":"T Takenaka","year":"2012","unstructured":"Takenaka T, Seto T, Okayama M, Kojima E, Nodaira Y, Sueyoshi K, Kikuta T, Watanabe Y, Inoue T, Takane H, Ohno Y, Suzuki H. Long-term effects of calcium antagonists on augmentation index in hypertensive patients with chronic kidney disease: a randomized controlled study. Am J Nephrol. 2012;35:416\u201323.","journal-title":"Am J Nephrol"},{"key":"601_CR12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/10641961003628510","volume":"32","author":"X Zhao","year":"2010","unstructured":"Zhao X, Wu F, Jia S, Qu P, Li H, Zhao X, Cao B, Lin Y, Wang M. Azelnidipine and amlodipine: a comparison of their effects and safety in a randomized double-blinded clinical trial in Chinese essential hypertensive patients. Clin Exp Hypertens. 2010;32:372\u20136.","journal-title":"Clin Exp Hypertens"},{"key":"601_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1291\/hypres.29.767","volume":"29","author":"T Yamagishi","year":"2006","unstructured":"Yamagishi T. Efficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: comparison with amlodipine. Hypertens Res. 2006;29:767\u201373.","journal-title":"Hypertens Res"},{"key":"601_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13098-015-0073-9","volume":"7","author":"K Tawaramoto","year":"2015","unstructured":"Tawaramoto K, Kaneto H, Hashiramoto M, Kawasaki F, Tatsumi F, Shimoda M, Kamei S, Matsuki M, Mune T, Kaku K. Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study). Diabetol Metab Syndr. 2015;7:80.","journal-title":"Diabetol Metab Syndr"},{"key":"601_CR15","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/echo.12548","volume":"31","author":"H Motoki","year":"2014","unstructured":"Motoki H, Koyama J, Izawa A, Tomita T, Miyashita Y, Takahashi M, Ikeda U. Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy. Echocardiography. 2014;31:1230\u20138.","journal-title":"Echocardiography"},{"key":"601_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1291\/hypres.26.201","volume":"26","author":"K Kuramoto","year":"2003","unstructured":"Kuramoto K, Ichikawa S, Hirai A, Kanada S, Nakachi T, Ogihara T. Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure. Hypertens Res. 2003;26:201\u20138.","journal-title":"Hypertens Res"},{"key":"601_CR17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1253\/circj.CJ-11-0141","volume":"75","author":"T Kojima","year":"2011","unstructured":"Kojima T, Miyauchi K, Yokoyama T, Yokoyama K, Kurata T, Suwa S, Kawamura M, Tamura H, Okazaki S, Inoue K, Fujiwara Y, Sumiyoshi M, Tanimoto K, Nakazato Y, Yamagami S, Hiro T, Komiyama N, Daida H. Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo University (ALPS-J). Circ J. 2011;75:1071\u20139.","journal-title":"Circ J"},{"key":"601_CR18","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1097\/HJH.0000000000000270","volume":"32","author":"J Inomata","year":"2014","unstructured":"Inomata J, Murai H, Kaneko S, Hamaoka T, Ikeda T, Kobayashi D, Usui S, Furusho H, Sugiyama Y, Takata S, Takamura M. Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension. J Hypertens. 2014;32:1898\u2013904.","journal-title":"J Hypertens"},{"key":"601_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-10-79","volume":"10","author":"K Fukao","year":"2011","unstructured":"Fukao K, Shimada K, Hiki M, Kiyanagi T, Hirose K, Kume A, Ohsaka H, Matsumori R, Kurata T, Miyazaki T, Daida H. Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and endothelial function\u2014a crossover trial (AGENT). Cardiovasc Diabetol. 2011;10:1\u201312.","journal-title":"Cardiovasc Diabetol"},{"key":"601_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/FJC.0b013e31804d1cf1","volume":"49","author":"K Eguchi","year":"2007","unstructured":"Eguchi K, Tomizawa H, Ishikawa J, Hoshide S, Fukuda T, Numao T, Shimada K, Kario K. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure. J Cardiovasc Pharmacol. 2007;49:394\u2013400.","journal-title":"J Cardiovasc Pharmacol"},{"key":"601_CR21","unstructured":"An updated guideline for reporting systematic reviews [Internet]. Equator Network; 2020. https:\/\/www.equator-network.org [cited 2022 Dec 24]."},{"key":"601_CR22","unstructured":"PROSPERO [Internet]. University of York. https:\/\/www.crd.york.ac.uk\/prospero\/ [cited 2023 Jan 17]."},{"key":"601_CR23","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training [Internet]. https:\/\/training.cochrane.org\/handbook [cited 2022 Dec 24]."},{"key":"601_CR24","unstructured":"RoB 2: A revised Cochrane risk-of-bias tool for randomized trials | Cochrane Bias [Internet]. https:\/\/methods.cochrane.org\/bias\/resources\/rob-2-revised-cochrane-risk-bias-tool-randomized-trials [cited 2022 Dec 24]."},{"key":"601_CR25","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training [Internet]. https:\/\/training.cochrane.org\/handbook#how-to-cite [cited 2023 Aug 20]."},{"key":"601_CR26","first-page":"11273","volume":"10","author":"Y Xiao","year":"2017","unstructured":"Xiao Y, Hu G. The effects of azelnidipine and amlodipine in treatment of mild to moderate hypertension: a systematic review. Int J Clin Exp Med. 2017;10:11273\u201381.","journal-title":"Int J Clin Exp Med"},{"key":"601_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/147323000403200210","volume":"32","author":"K Shinomiya","year":"2004","unstructured":"Shinomiya K, Mizushige K, Fukunaga M, Masugata H, Ohmori K, Kohno M, Senda S. Antioxidant effect of a new calcium antagonist, azelnidipine, in cultured human arterial endothelial cells. J Int Med Res. 2004;32:170\u20135.","journal-title":"J Int Med Res"},{"issue":"6","key":"601_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40292-020-00412-y","volume":"27","author":"AA Sofy","year":"2020","unstructured":"Sofy AA, Abdelsattar AT, Mohammed OM, Shareef MA, Alamodi AA, Nso N, Payton M, Masoud AT. Amlodipine compared with benidipine in the management of hypertension: a systematic review and meta-analysis. High Blood Press Cardiovasc Prev. 2020;27(6):527\u201337.","journal-title":"High Blood Press Cardiovasc Prev."},{"key":"601_CR29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40119-022-00276-4","volume":"11","author":"CVS Ram","year":"2022","unstructured":"Ram CVS. Therapeutic usefulness of a novel calcium channel blocker azelnidipine in the treatment of hypertension: a narrative review. Cardiol Ther. 2022;11:473\u201389.","journal-title":"Cardiol Ther"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-023-00601-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-023-00601-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-023-00601-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T04:14:40Z","timestamp":1698207280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-023-00601-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["601"],"URL":"https:\/\/doi.org\/10.1007\/s40292-023-00601-5","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"19 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ESM Update","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We took approval from the Institutional Ethics Committee before conducting this study. Reference Number: T\/IM-NF\/Pharm\/22\/141.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All data of this work are available through contacting the corresponding author.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data"}},{"value":"Debkumar Pal: Concept and design, Literature Search, Study selection and data collection, Data extraction and management, and drafting of the manuscript, Final approval of the manuscript. Shampa Maji: Literature Search, Study selection and data collection, Data Analysis and interpretation of data, Critical revision of the manuscript for important intellectual content, Final approval of the manuscript. Rituparna Maiti: Study selection and data collection, data extraction and management, Data Analysis and interpretation of data, Critical revision of the manuscript for important intellectual content, Final approval of the manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}